TABLE 2.
PEER-REVIEWED PUBLISHED REPLICATION STUDIES FOR POSITIONALLY CLONED ASTHMA SUSCEPTIBILITY GENES IN THE ENGLISH LANGUAGE LITERATURE
Study: First Author (Ref.) | No. SNPs Typed | Associations with Asthma*
|
Additional Phenotypes | Association Results | Level of Replication
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Population | Sample Size | Design | Single Marker | Haplotype | Phenotype | Marker | ||||||||||||||
ADAM33 | ||||||||||||||||||||
Lind (47) | Puerto Rican | 318 trios | FBTA | 6 | NS | NS | IgE | NS | No | No | ||||||||||
Mexican | 265 trios | FBTA | 6 | NS | NS | IgE | NS | No | No | |||||||||||
Howard (48) | Dutch | 153 cases, 124 controls | CC | 8 | ST+7, V4 | Yes | IgE | NS | Yes | Yes | ||||||||||
African American | 160 cases, 256 controls | CC | 8 | S2 | Yes | IgE | NS | Yes | No | |||||||||||
US white | 219 cases, 225 controls | CC | 8 | ST+7, T1, T2 | Yes | IgE | NS | Yes | Yes | |||||||||||
US Hispanic | 112 cases, 126 controls | CC | 8 | S2, T2 | NS | IgE | NS | Yes | No | |||||||||||
Werner (30) | German white | 171 families, 732 subjects | FBTA | 15 | F+1, ST+4, ST+5 | Yes | IgE | F+1, ST+5 | Yes | Yes | ||||||||||
AHR | F+1, S2 | |||||||||||||||||||
German white | 48 cases, 499 controls | CC | 15 | ST+7 | Yes | IgE | ST+7 | Yes | Yes | |||||||||||
AHR | ST+5 | |||||||||||||||||||
Lee (31) | Korean | 326 cases, 151 controls | CC | 5 | NS | NS | AHR | T1 | No | No | ||||||||||
Raby (22) | US white | 474 families | FBTA | 17 | NS | NS | IgE, AHR | NS | No | No | ||||||||||
African American | 66 families | FBTA | 17 | NS | NS | IgE, AHR | NS | No | No | |||||||||||
US Hispanic | 47 families | FBTA | 17 | T1, T+1 | Yes | IgE | T1, T+1 | Yes | No | |||||||||||
AHR | NS | |||||||||||||||||||
Blakey (49) | Iceland | 348 cases, 262 controls | CC | 13 | NS | NR | No | No | ||||||||||||
UK | 60 families, 240 subjects | FBTA | 13 | NS | NR | No | No | |||||||||||||
Simpson (50) | UK | 470 children | Cohort | 17 | NS | NS | FEV1 | F+1, M+1, T1, T2 | No | No | ||||||||||
Kedda (51) | Australian white | 612 cases, 473 controls | CC | 10 | NS | Yes | No | No | ||||||||||||
Schedel (52) | German white | 624 cases, 1,248 controls | CC | 10 | NS | Yes | AHR | NS | No | No | ||||||||||
German white | 824 children | Cohort | 10 | NS | NS | AHR | NS | No | No | |||||||||||
Hirota (53) | Japanese | 504 cases, 651 controls | CC | 14 | S2, T1, T2, V-3 | Yes | IgE | NS | Yes | No | ||||||||||
Wang (54) | Chinese | 296 cases, 270 controls | CC | 3 | NS | NS | No | No | ||||||||||||
Noguchi (55) | Japanese | 155 families, 538 subjects | FBTA | 23 | S+1, ST+4, T2 | NS | IgE | NS | Yes | Yes | ||||||||||
GPR154 | ||||||||||||||||||||
Shin (56) | Korean | 439 cases, 374 controls | CC | 1 | NS | — | IgE, AHR | NS | No | No | ||||||||||
Melen (57) | Western European | 265 cases, 2,848 controls | CC† | 7 | NR | H5 | Allergic sensitization | H5, H6 | Yes | Yes | ||||||||||
Swedish | 176 cases, 624 controls | CC | 7 | NR | NS | Allergic sensitization | NS | No | No | |||||||||||
Kormann (32) | German white | 351 cases, 1,769 controls | CC | 6 | 546333, 585883 | H4 | Yes | Yes | ||||||||||||
AHR | NS | |||||||||||||||||||
German white | 112 cases, 1,737 controls | CC | 6 | IgE | 546333, 585883 | |||||||||||||||
Feng (33) | Chinese | 451 cases, 232 controls | CC | 7 | NR | NS | AHR | rs324981, rs324987 | No | No | ||||||||||
Chinese | 264 cases, 241 controls | CC | 1 | AHR | NS | |||||||||||||||
Malerba (58) | Italian | 211 families, 927 subjects | FBTA | 7 | NS | H5, H6 | IgE | 546333, 585883, H4 | Yes | Yes |
Included here are all published studies in the English literature that test for genetic association with asthma or a related phenotype and include at least one population with a minimum of 100 cases and 100 controls or 100 families. Studies that do not include reports of association testing with asthma are not included. An association is claimed if reported with a p value less than 0.05 in the primary report. Marker replication is claimed only if the marker associated in the replication study is that reported in the initial study. Combination phenotypes (i.e., asthma + AHR) are not considered. For ADAM33, the six markers associated with asthma in the combined population in reference (8) were Q-1, S1, ST+4, ST+7, V-1, and V4. For GPR154, the primary replication is for haplotypes H2, H4, H5, and H7, and for SNP522363, which differentiates these risk haplotypes from three nonrisk haplotypes (H1, H3, and H6).
SNPs associated with asthma are listed.
Population-based case–control study.